UNSPSC 51162333: Aspirin/phenyltoloxamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162333 Aspirin/phenyltoloxamine is a Commodity code that encompasses pharmaceutical products, though recent state and local solicitations tagged under this code show activity focused on naloxone, safe drug deactivation systems, and generic multi-source pharmaceuticals and over-the-counter products rather than aspirin or phenyltoloxamine specifically. State and local buyers under this code include county health departments, state departments of administration overseeing cooperative purchasing, and participating municipalities and local government facilities. The work involves procurement of finished pharmaceutical products, with vendors responsible for meeting FDA compliance, current Good Manufacturing Practices certification, Drug Supply Chain Security Act adherence, and supply-chain security requirements including proper expiration dating and shelf-life minimums.

Recent activity spans Florida and Minnesota. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2026. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 on January 20, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon, with proposals due March 26, 2026. Both solicitations require vendors to demonstrate pricing competitiveness, maintain comprehensive insurance including commercial general liability coverage, and comply with federal and state regulatory frameworks. The mismatch between the code's nominal scope (aspirin/phenyltoloxamine) and actual recent procurement activity (naloxone, generic pharmaceuticals, OTC products) suggests the code may be capturing pharmaceutical procurement activity more broadly rather than this specific drug combination.